The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia

Introduction: Heart failure (HF) has high morbidity and mortality rates. Spironolactone has shown a 30% reduction in all-cause mortality, reduction in hospitalizations, and sudden death. However, data shows low use of spironolactone in HF patients. We aim to assess spironolactone utilization in HF r...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Abdulmalik S, Alabdan, Numan, Alotaibi, Abdullah M, Aljaafary, Haifa, Alqahtani, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515793/
https://www.ncbi.nlm.nih.gov/pubmed/32983725
http://dx.doi.org/10.7759/cureus.10032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515793/
https://www.ncbi.nlm.nih.gov/pubmed/32983725
http://dx.doi.org/10.7759/cureus.10032

Ejemplares similares